Instructor in Surgery
Harvard Medical School
Chief Medical Officer
The Vascular Care Group/Mangrove Management Partners
Boston, Massachusetts
Presenter
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Panelist
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Session Moderator
SESSION 41: OPEN AND ENDO TREATMENT OF COMPLEX AAAS (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAS; INTERESTING NEW DEVICES FOR THEIR TREATMENT
Presenter
SESSION 37: MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLS)
Session Moderator
SESSION 56: NEW OR UPDATED DEVICES FOR STANDARD EVAR OR F/B/EVAR
Presenter
SESSION 56: NEW OR UPDATED DEVICES FOR STANDARD EVAR OR F/B/EVAR
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
The AngioVac Strategy For The Treatment Of PE
10:10 AM - 10:20 AM
Panelist
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
11:35 AM - 12:00 PM
Session Moderator
SESSION 41: OPEN AND ENDO TREATMENT OF COMPLEX AAAS (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAS; INTERESTING NEW DEVICES FOR THEIR TREATMENT
Presenter
SESSION 37: MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLS)
How To Make Outpatient Vascular Treatment Facilities (OBLs, ASCs) Safe, Effective And Profitable Without Doing Unjustified Procedures: How Can They Make Uniquely Important Vascular Research Contributions
4:20 PM - 4:25 PM
Session Moderator
SESSION 56: NEW OR UPDATED DEVICES FOR STANDARD EVAR OR F/B/EVAR
Presenter
SESSION 56: NEW OR UPDATED DEVICES FOR STANDARD EVAR OR F/B/EVAR
AFX 2 Anatomically Fixed (On The Aortic Bifurcation) Endografts For AAA Repair: The LEOPARD RCT 5-Year Results Show It Has Similar Outcomes To Other Widely Used Proximally Fixed Endografts
8:30 AM - 8:35 AM
OUTPATIENT FACILITIES FOR VASCULAR PROCEDURES AND CLINICAL RESEARCH
FRIDAY, NOVEMBER 22, 2024
AMERICAS HALL 1, 3RD FLOOR
PRESENTER
1:33 PM - 1:41 PM
External Funding for OBLs and ASCs: When is it Necessary? Venture Capital or Private Equity? The Upside Is Capital, but What are the Downsides?
FRIDAY, NOVEMBER 22, 2024
AMERICAS HALL 1, 3RD FLOOR
PRESENTER
1:33 PM - 1:41 PM
External Funding for OBLs and ASCs: When is it Necessary? Venture Capital or Private Equity? The Upside Is Capital, but What are the Downsides?